Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 31, 2018
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-01-29$4.81/sh−2,830$13,612→ 136,870 total
Footnotes (2)
- [F1]Sale of a total of 2,830 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 8,228 shares of restricted stock on January 28, 2018. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 74,164 shares of restricted stock.